|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-5-14
|
|
pubmed:abstractText |
To investigate the protective effects of cistanche total glycosides (CTG) on dopaminergic neuron in substantia nigra (SN) of model mice of Parkinson's disease (PD).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1003-5370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-51
|
|
pubmed:meshHeading |
pubmed-meshheading:18476428-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:18476428-Animals,
pubmed-meshheading:18476428-Behavior, Animal,
pubmed-meshheading:18476428-Cistanche,
pubmed-meshheading:18476428-Dopamine,
pubmed-meshheading:18476428-Drugs, Chinese Herbal,
pubmed-meshheading:18476428-Glycosides,
pubmed-meshheading:18476428-Immunohistochemistry,
pubmed-meshheading:18476428-Male,
pubmed-meshheading:18476428-Mice,
pubmed-meshheading:18476428-Mice, Inbred C57BL,
pubmed-meshheading:18476428-Neurons,
pubmed-meshheading:18476428-Neuroprotective Agents,
pubmed-meshheading:18476428-Parkinson Disease, Secondary,
pubmed-meshheading:18476428-Random Allocation,
pubmed-meshheading:18476428-Substantia Nigra,
pubmed-meshheading:18476428-Tyrosine 3-Monooxygenase
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Protective effects of Cistanche total glycosides on dopaminergic neuron in substantia nigra of model mice of Parkinson's disease].
|
|
pubmed:affiliation |
Laboratory for Neurology, Institute of Integrative Medicine, Zhongshan Hospital, Shanghai.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
